Registration Link
http://www.scgcorp.com/NeonatalAKI2013 
Event Details
Due to the limited size of the meeting room, there is no onsite registration for this meeting. If the online registration is closed, that means that we have hit the maximum number of people and cannot register anybody else. Thank you.
Meeting Purpose:
The purpose of this conference is to: (1) review the state-of-the-art knowledge of acute kidney injury (AKI) in neonates; and (2) determine the feasibility of studying this group in an organized prospective manner. This conference will bring together experts from the fields of pediatric nephrology, neonatology, general pediatrics, industry, and professional organizations to get a broad perspective on the issues to be considered.
Meeting Planning Committee:
Marva Moxey-Mims, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Paul Kimmel, M.D.
NIDDK
Rosemary Higgins, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Tonse Raju, M.D.
NICHD
Stuart Goldstein, M.D.
Cincinnati Children’s Hospital Medical Center
Timothy Bunchman, M.D.
Virginia Commonwealth University
David Askenazi, M.D.
University of Alabama at Birmingham
Namasivayam Ambalavanan, M.D.
University of Alabama at Birmingham
Catherine Morgan, M.D., M.Sc.
University of Alberta
P. Brian Smith, M.D., M.P.H., M.H.S.
Duke University Medical Center
Matthew M. Laughon, M.D., M.P.H.
University of North Carolina, Chapel Hill
For logistical questions, please contact Ms. Mary Allen at mallen@scgcorp.com, or (301) 670-4990.
Agenda
| 7:30 a.m. |
Registration |
| Session 1—Neonatal AKI Epidemiology Today |
| 8:00 a.m. |
AKI Definitions—Do They Make Sense in Neonates?
Michael Zappitelli, M.D. |
| 8:15 a.m. |
Risk Factors for AKI
Namasivayam Ambalavanan, M.D. |
| 8:30 a.m. |
Outcomes in Neonatal AKI
David Askenazi, M.D. |
| |
|
|
Session 2—Neonatal AKI From the Bench to Bedside |
| 8:45 a.m. |
Impact on the Developing Nephron
Patrick Brophy, M.D. |
| 9:00 a.m. |
Biomarkers
Stuart Goldstein, M.D. |
| 9:15 a.m. |
What Do We Know About Long-term Kidney Outcomes in Neonatal Survivors?
Cherry Mammen, M.D. |
| 9:30 a.m. |
What Do We Know About Long-term Neonatal Cardiac Surgery Associated AKI Outcomes?
Catherine Morgan, M.D. |
| 9:45 a.m. |
Break |
| |
|
|
Session 3—How Will We Study Long-term Neonatal AKI Outcomes: Lessons From Other Neonatal Studies |
| 10:15 a.m. |
The PROP Study
James Greenberg, M.D. |
| 10:35 a.m. |
The Neonatal Network
Rosemary Higgins, M.D. |
| 10:55 a.m. |
The Kaiser Permanente Experience
Michael Kuzniewicz, M.D. |
| 11:15 a.m. |
The Pediatrix™ Experience
P. Brian Smith, M.D. |
| |
|
| Working Lunch/Breakout Sessions |
| 11:45 a.m. |
Group 1—Developing the Neonatal AKI Definition
Group Leaders: Drs. Michael Zappitelli and Namasivayam Ambalavanan |
| 11:45 a.m. |
Group 2—Developing the Feasible Neonatal AKI Study
Group Leaders: Drs. Catherine Morgan and Rosemary Higgins |
| 11:45 a.m. |
Group 3—Challenges to Long-term Neonatal AKI Followup From NICU Discharge to 6 Years of Age
Group Leaders: Drs. David Askenazi and Matthew Laughon |
| |
|
|
Breakout Group Reports |
| 2:15 p.m. |
Group 1 |
| 3:00 p.m. |
Group 2 |
| 3:45 p.m. |
Group 3 |
| 4:30 p.m. |
Wrap-up and Assignments |
| 5:00 p.m. |
Adjournment |
| |
|
[Back to Top]
Contact
For logistical questions, please contact Ms. Mary Allen at mallen@scgcorp.com, or (301) 670-4990.
[Back to Top]
Page last updated: March 21, 2013
